Koichiro Yoneyama, MSc

Pharmaceutical Science Dept.
Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
Tokyo, Tokyo, Japan

Koichiro Yoneyama, MSc, Pharmaceutical Science Dept., Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
He joined Chugai in 2007 after graduating from Meiji Pharmaceutical University with a MSc degree. He has been working on clinical pharmacology and pharmacometrics for the translational research and clinical development of new drugs regardless of the drug modality, disease area, and development stage, with a special focus on hemophilia since 2010.

Presentation(s):

• OC 06.3 - Final Analysis Results from a Phase III Study of Emicizumab Prophylaxis for Acquired Hemophilia A (AGEHA)

  Saturday, June 24, 2023
  13:30 – 13:45 ET

• OC 69.4 - Safety, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous Injection of NXT007, an Emicizumab-Based Next-Generation Bispecific Antibody, in Healthy Volunteers (NXTAGE Study)

  Wednesday, June 28, 2023
  11:00 – 11:15 ET